Physician profile
Haley Ann Burke
NPI 1861717555
$54,511.49
in general payments reported to CMS, 2019-2025
41 companies · $792 in 2025
The $792 reported for 2025 was more than what a typical Pain Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $405).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $7,812 · 2021: $7,365 · 2022: $1,670 · 2023: $1,398 · 2024: $533 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,723.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $48,634.76 | 2019-2022 | |
| Abbvie INC. | $1,415.11 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Boston Scientific Corporation | $622.30 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, G4 Rf Generator |
| Allergan, INC. | $497.52 | 2019-2022 | |
| Pfizer INC. | $376.55 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $260.08 | 2019-2025 | Ztlido |
| Spr Therapeutics, INC | $251.04 | 2022-2025 | Sprint Pns System |
| Biohaven Pharmaceuticals, INC. | $179.85 | 2021 | |
| Lundbeck LLC | $178.55 | 2021-2025 | Vyepti |
| Lilly USA, LLC | $174.90 | 2019-2022 | |
| Saluda Medical Americas, INC. | $174.88 | 2024-2025 | Evoke |
| Jazz Pharmaceuticals INC. | $147.38 | 2023 | Epidiolex |
| Neurocrine Biosciences, INC. | $139.99 | 2021 | |
| Collegium Pharmaceutical, INC. | $138.47 | 2022-2025 | Belbuca, Xtampza |
| Supernus Pharmaceuticals, INC. | $137.10 | 2019-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.